Reborn Coffee Announces Grand Opening of Flagship Store in Kuala Lumpur, Malaysia
December 01, 2023 08:31 ET
|
REBORN COFFEE, INC.
Reborn Coffee Announces Grand Opening of Flagship Store in Kuala Lumpur, Malaysia
Avenue Therapeutics to Present at American Epilepsy Society 2023 Annual Meeting
December 01, 2023 08:30 ET
|
Avenue Therapeutics
MIAMI, Dec. 01, 2023 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company focused on the development and commercialization of...
Xcel Brands, Inc. to Present at Upcoming Investor Conferences
December 01, 2023 08:30 ET
|
Xcel Brands, Inc
NEW YORK, Dec. 01, 2023 (GLOBE NEWSWIRE) -- Xcel Brands, Inc. (NASDAQ: XELB) (“Xcel” or the “Company”), a media and consumer products company with significant expertise in livestream shopping and...
GeneDx Presents New Data at the American Epilepsy Society Annual Meeting Demonstrating That Exome Sequencing Outperforms Multi-Gene Panels for Patients with Epilepsy
December 01, 2023 08:30 ET
|
GeneDx Holdings Corp.
STAMFORD, Conn., Dec. 01, 2023 (GLOBE NEWSWIRE) -- GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic and clinical insights, today announced new data to be...
Navitas Showcases High-power Semiconductors for EV, Solar & Industrial at Next-gen Munich Conference
December 01, 2023 08:30 ET
|
Navitas Semiconductor Corporation
TORRANCE, Calif., Dec. 01, 2023 (GLOBE NEWSWIRE) -- Navitas Semiconductor (Nasdaq: NVTS), the industry leader in next-generation GaNFast™ gallium nitride (GaN) and GeneSiC™ silicon carbide (SiC)...
Allogene Therapeutics Announces Participation in December Investor Conference
December 01, 2023 08:30 ET
|
Allogene Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., Dec. 01, 2023 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T...
Trust Stamp ® Announces the Fortieth Financial Institution to start integration with the Company’s Orchestration Layer
December 01, 2023 08:30 ET
|
Trust Stamp
ATLANTA, Dec. 01, 2023 (GLOBE NEWSWIRE) -- Trust Stamp (Nasdaq: IDAI), the Privacy-First Identity CompanyTM, today provides an update regarding the adoption of its low-code Orchestration Platform,...
Clover Health Exits ACO REACH to Accelerate Path to Profitability
December 01, 2023 08:15 ET
|
Clover Health Investments, Corp.
FRANKLIN, Tenn., Dec. 01, 2023 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement company committed to bringing...
Weight loss MEAI: Clearmind Medicine’s Novel Obesity Drug Showed Positive Results in a Pre-Clinical Trial
December 01, 2023 08:14 ET
|
Clearmind Medicine Inc.
The collaboration between Clearmind and SciSparc continues to yield positive results in its obesity and Metabolic disorder program Tel Aviv, Israel / Vancouver, Canada, Dec. 01, 2023 (GLOBE...
Weight Loss Treatment: SciSparc’s Obesity Drug Showed Positive Results in a Pre-Clinical Trial
December 01, 2023 08:14 ET
|
SciSparc Ltd
The collaboration between SciSparc and Clearmind continues to yield positive results in its obesity and metabolic disorder program TEL AVIV, Israel, Dec. 01, 2023 (GLOBE NEWSWIRE) -- SciSparc...